The merger bolsters Hill-Rom’s footprint in surgical devices with Aspen’s safety scalpels and blades, fluid collection products, specialty needs and other operating room disposables and instruments.
"With the addition of Aspen Surgical, Hill-Rom is well positioned for growth and geographic expansion in our surgical business, particularly in the safety product segments," president & CEO John Greisch said in prepared remarks. "This acquisition further expands our global portfolio beyond our core franchise with a business that is immediately accretive to earnings per share and adds recurring revenue to our existing surgical platform."
Aspen has annual sales of about $120 million, and Hill-Rom expects the acquisition to add 2¢ to its bottom line for fiscal 2012, according to a press release.
That’s good news for Hill-Rom, which earlier this year announced plans to lay off about 3% of its workforce, roughly 200 employees, ahead of the 2.3% medical device tax.
Batesville, Ind.-based Hill-Rom also said it’s taking a $10 million to $13 million hit this year on tangible and intangible impairments, meaning a total charge of $19 million to $22 million for 2012.
HRC shares lost 17.7% in trading today, with shares going for $25.94 apiece after the company missed by a penny Wall Street’s Q3 expectations of 57¢ per share in earnings.
On June 4-5, DeviceTalks Minnesota is taking over the Twin Cities medtech industry with one of the most anticipated conferences of the spring.
Join leaders from 3M, Abbott, Bigfoot Biomedical, Boston Scientific, Cardionomic, CMF Solutions, Cyient, Google Mayo Clinic, Medical Alley, Medtronic, NxThera, Opus College, Relievant Medsystems, University of Minnesota, Star Tribune, Smith & Nephew, Spry Health, Zimmer Biomet and many more when you register today.
Use the code "DTWeb" to save 15% on the cost of registration.